Details for New Drug Application (NDA): 020591
✉ Email this page to a colleague
The generic ingredient in TARKA is trandolapril; verapamil hydrochloride. There are ten drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the trandolapril; verapamil hydrochloride profile page.
Summary for 020591
Tradename: | TARKA |
Applicant: | Abbvie |
Ingredient: | trandolapril; verapamil hydrochloride |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 2MG;180MG | ||||
Approval Date: | Oct 22, 1996 | TE: | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 4MG;240MG | ||||
Approval Date: | Oct 22, 1996 | TE: | RLD: | Yes |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 1MG;240MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Oct 22, 1996 | TE: | RLD: | Yes |
Expired US Patents for NDA 020591
Complete Access Available with Subscription